The anti-obesity drug ‘Rimonabant’ is likely to face a ban in India, after studies in Europe found a likelihood of psychiatric side effects upon use of the drug.
The drug, manufactured by the Pharmaceutical Company, Sanofi Aventis was launched in Europe in 2006. Seventeen companies in India produce the generic version of this drug.
Search On for Anti-obesity Drugs Despite Failures
Designers of anti-obesity drugs have suffered three major setbacks, but the potential reward from treating the world's fat epidemic is so great that their quest is unlikely to be deterred.
Designers of anti-obesity drugs have suffered three major setbacks, but the potential reward from treating the world's fat epidemic is so great that their quest is unlikely to be deterred.
“We have also communicated the same to all state licensing authorities and they have been asked to make sure that the drug is not produced in the country, he added.
The European drug watchdog had issued a warning to member countries to stop the sale of this drug as quickly as possible.
Anti-obesity Drug Goes Off-sale in Europe
EU authorities suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent Thursday, the firm announced, adding that it had not ruled out a worldwide halt.
EU authorities suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent Thursday, the firm announced, adding that it had not ruled out a worldwide halt.
Advertisement
Anti-obesity Drugs may Hinder Neural Development in Kids
Researchers from Massachusetts Institute of Technology have warned that new anti-obesity drugs may interfere with neural development in kids.
Researchers from Massachusetts Institute of Technology have warned that new anti-obesity drugs may interfere with neural development in kids.
SAV
Mechanism Behind Regulation of Food Intake Identified
Researchers from have identified a mechanism that helps regulate food intake - a finding that may help in developing new anti-obesity drugs with fewer side effects.
Researchers from have identified a mechanism that helps regulate food intake - a finding that may help in developing new anti-obesity drugs with fewer side effects.
